Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia
- Author
- CELLA, G1 ; VETTOR, R1 ; SBARAI, A1 ; ROSSI, E1 ; RAMPIN, E1 ; MACOR, C1 ; MUSSAP, M1 ; PLEBANI, M2 ; LUZZATTO, G1 ; GIROLAMI, A1
[1] Institute of Medical Semeiotics, University of Padua, Medical School, Padua, Italy
[2] Central Laboratory, Padua General Hospital, Padua, Italy - Issue title
- Basic and clinical considerations of heparins. Part II
- Author (monograph)
- HARENBERG, Job (Editor)1
[1] 1st Department of Medicine, Faculty of Clinical Medicine Mannheim, University of Heidelberg, Klinikum Mannheim, 68167 Mannheim, Germany - Source
Seminars in thrombosis and hemostasis. 1997, Vol 23, Num 2, pp 129-134 ; ref : 35 ref
- CODEN
- STHMBV
- ISSN
- 0094-6176
- Scientific domain
- Cardiology, blood circulation, phlebology; Hematology
- Publisher
- Thieme, New York, NY
/
Thieme, Stuttgart
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antigène Athérosclérose Cellule endothéliale Etat nutritionnel Facteur tissulaire Glycosaminoglycane Homme Hyperinsulinémie Héparine Inhibiteur Lipide Obésité Pathogénie Appareil circulatoire pathologie Trouble nutrition Vaisseau sanguin pathologie
- Keyword (en)
- Antigen Atherosclerosis Endothelial cell Nutritional status Tissue factor Glycosaminoglycan Human Hyperinsulinemia Heparin Inhibitor Lipids Obesity Pathogenesis Cardiovascular disease Nutrition disorder Vascular disease
- Keyword (es)
- Antígeno Ateroesclerosis Célula endotelial Estado nutricional Factor tisular Glicosaminoglicano Hombre Hiperinsulinemia Heparina Inhibidor Lípido Obesidad Patogenia Aparato circulatorio patología Trastorno nutricíon Vaso sanguíneo patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B01 Atherosclerosis (general aspects, experimental research)
- Discipline
- Cardiology. Circulatory system
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2746894
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1055/s-2007-996080 
https://dx.doi.org/10.1055/s-2007-996080
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-996080\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"129\";s:8:\"\u0000*\u0000epage\";s:3:\"134\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CELLA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"VETTOR, R\";i:1;s:9:\"SBARAI, A\";i:2;s:8:\"ROSSI, E\";i:3;s:9:\"RAMPIN, E\";i:4;s:8:\"MACOR, C\";i:5;s:9:\"MUSSAP, M\";i:6;s:10:\"PLEBANI, M\";i:7;s:11:\"LUZZATTO, G\";i:8;s:11:\"GIROLAMI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Basic and clinical considerations of heparins. Part II\";s:8:\"\u0000*\u0000title\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-996080\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"129\";s:8:\"\u0000*\u0000epage\";s:3:\"134\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CELLA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"VETTOR, R\";i:1;s:9:\"SBARAI, A\";i:2;s:8:\"ROSSI, E\";i:3;s:9:\"RAMPIN, E\";i:4;s:8:\"MACOR, C\";i:5;s:9:\"MUSSAP, M\";i:6;s:10:\"PLEBANI, M\";i:7;s:11:\"LUZZATTO, G\";i:8;s:11:\"GIROLAMI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Basic and clinical considerations of heparins. Part II\";s:8:\"\u0000*\u0000title\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-996080\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-996080\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"129\";s:8:\"\u0000*\u0000epage\";s:3:\"134\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CELLA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"VETTOR, R\";i:1;s:9:\"SBARAI, A\";i:2;s:8:\"ROSSI, E\";i:3;s:9:\"RAMPIN, E\";i:4;s:8:\"MACOR, C\";i:5;s:9:\"MUSSAP, M\";i:6;s:10:\"PLEBANI, M\";i:7;s:11:\"LUZZATTO, G\";i:8;s:11:\"GIROLAMI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Basic and clinical considerations of heparins. Part II\";s:8:\"\u0000*\u0000title\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-996080\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"129\";s:8:\"\u0000*\u0000epage\";s:3:\"134\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CELLA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"VETTOR, R\";i:1;s:9:\"SBARAI, A\";i:2;s:8:\"ROSSI, E\";i:3;s:9:\"RAMPIN, E\";i:4;s:8:\"MACOR, C\";i:5;s:9:\"MUSSAP, M\";i:6;s:10:\"PLEBANI, M\";i:7;s:11:\"LUZZATTO, G\";i:8;s:11:\"GIROLAMI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Basic and clinical considerations of heparins. Part II\";s:8:\"\u0000*\u0000title\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:21:\"10.1055\/s-2007-996080\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:9:\"\u0000*\u0000jtitle\";s:37:\"Seminars in thrombosis and hemostasis\";s:9:\"\u0000*\u0000stitle\";s:21:\"Semin. thromb. hemost\";s:7:\"\u0000*\u0000date\";s:4:\"1997\";s:9:\"\u0000*\u0000volume\";s:2:\"23\";s:8:\"\u0000*\u0000issue\";s:1:\"2\";s:8:\"\u0000*\u0000spage\";s:3:\"129\";s:8:\"\u0000*\u0000epage\";s:3:\"134\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0094-6176\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"CELLA\";s:10:\"\u0000*\u0000aufirst\";s:1:\"G\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:9:\"VETTOR, R\";i:1;s:9:\"SBARAI, A\";i:2;s:8:\"ROSSI, E\";i:3;s:9:\"RAMPIN, E\";i:4;s:8:\"MACOR, C\";i:5;s:9:\"MUSSAP, M\";i:6;s:10:\"PLEBANI, M\";i:7;s:11:\"LUZZATTO, G\";i:8;s:11:\"GIROLAMI, A\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"STHMBV\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:54:\"Basic and clinical considerations of heparins. Part II\";s:8:\"\u0000*\u0000title\";s:140:\"Endothelial cell-associated tissue factor pathway inhibitor (TFPI) antigen in severe nondiabetic obese patients : Effect of hyperinsulinemia\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:6:\"Thieme\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
